The Göteborg randomised population based prostate cancer screening trial

Pas encore traduit Pas encore traduit
Catégorie Primary study
Registry of TrialsISRCTN registry
Year 2010

This article is not included in any systematic review

This article is part of the following publication threads:
  • ERSPC [European Randomized Study of Screening for Prostate Cancer] (44 documents)
Loading references information
Prostate specific antigen (PSA) screening decreases prostate cancer mortality by 40% after 15 years.
Epistemonikos ID: 634010693f79df8b7aa013678a12d357e63acbe3
First added on: Jul 31, 2019